Town, T; Paris, D; Parker, T A et al. (1999) Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E. Am J Med Genet 88:465-8
|
Crawford, F; Freeman, M; Town, T et al. (1999) No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples. Neurosci Lett 266:193-6
|
Crawford, F; Fallin, D; Suo, Z et al. (1998) The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett 249:115-8
|
Cai, X; Stanton, J; Fallin, D et al. (1997) No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Am J Med Genet 74:202-3
|
Cai, X; Fallin, D; Stanton, J et al. (1997) APOE is linked to Alzheimer's disease in a large pedigree. Am J Med Genet 74:365-9
|
Fallin, D; Gauntlett, A C; Scibelli, P et al. (1997) No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol 14:299-305
|
Fallin, D; Reading, S; Schinka, J et al. (1997) No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease. Am J Med Genet 74:192-4
|
Fallin, D; Kundtz, A; Town, T et al. (1997) No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett 233:145-7
|